Villas, Marie Sweet Ladyheart D.
HRN: 19-71-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CO-AMOXICLAV 625MG (TAB)
03/27/2026
04/03/2026
PO
625mg
TID
UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines